PIRMELLA 1/35 Drug Patent Profile
✉ Email this page to a colleague
When do Pirmella 1/35 patents expire, and what generic alternatives are available?
Pirmella 1/35 is a drug marketed by Lupin Ltd and is included in one NDA.
The generic ingredient in PIRMELLA 1/35 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PIRMELLA 1/35?
- What are the global sales for PIRMELLA 1/35?
- What is Average Wholesale Price for PIRMELLA 1/35?
Summary for PIRMELLA 1/35
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| DailyMed Link: | PIRMELLA 1/35 at DailyMed |
US Patents and Regulatory Information for PIRMELLA 1/35
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lupin Ltd | PIRMELLA 1/35 | ethinyl estradiol; norethindrone | TABLET;ORAL-28 | 201512-001 | Apr 24, 2013 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
